| 1. |
Burrell LST,Ross JM.A case of chylous effusion due to leiomyosacoma.Br J Tuberc,1937,31:382 39.
|
| 2. |
Ye L,Jin M,Bai C.Clinical analysis of patients with pulmonary lymphangioleiomyomatosis (PLAM) in mainland China.Respir Med,2010,104:1521-1526.
|
| 3. |
Johnson SR.Lymphangioleiomyomatosis.Eur Respir J,2006,27:1056-1065.
|
| 4. |
胡紅,趙會澤,段晉慶,等.肺淋巴管肌瘤病一例.中華結核和呼吸雜志,1998,21:367-368.
|
| 5. |
Johnson S.Rare diseases.1.Lymphangioleiomyomatosis:clinical features,management and basic mechanisms.Thorax,1999,54:254-264.
|
| 6. |
Baldi BG,Medeiros Junior P,Pimenta SP,et al.Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis.J Bras Pneumol,2011,37:375-379.
|
| 7. |
Oprescu N,McCormack FX,Byrnes S,et al.Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis:a population-based registry.Lung,2013,191:35-42.
|
| 8. |
Taveira-Dasilva AM,Moss J.Optimizing treatments for lyphangioleiomyomatosis. J Expert Rev Respir Med,2012,6:267-276.
|
| 9. |
Moua T,Olson EJ,Jean H CS,et al.Resolution of chylous pulmonary congestion and respiratory failure in lymphangioleiomyomatosis with sirolimus therapy.Am J Respir Crit Care Med,2012,186:389-390.
|
| 10. |
Barrera P,Simons SO,Luijk B,et al.Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis.Ann Am Thorac Soc,2013,10:408-409.
|
| 11. |
Ando K,Kurihara M,Kataoka H,et al.The efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis.Respir Investig,2013,51:175-183.
|
| 12. |
高俊,朱培菊,張尚福,等.肺淋巴管平滑肌瘤病的臨床病理分析.中國肺癌雜志,2011,14:378-382.
|
| 13. |
Riojas RA,Bahr BA,Thomas DB,et al.A case report of lymphangioleiomyomatosis presenting as spontaneous pneumothorax.Mil Med,2012,177:477-480.
|
